Compare CVKD & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVKD | WETH |
|---|---|---|
| Founded | 2022 | 1992 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 16.6M |
| IPO Year | 2023 | N/A |
| Metric | CVKD | WETH |
|---|---|---|
| Price | $7.32 | $1.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 51.9K | ★ 53.1K |
| Earning Date | 03-12-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.55 |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $43,519,385.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.74 |
| Revenue Growth | N/A | ★ 6.08 |
| 52 Week Low | $6.42 | $0.76 |
| 52 Week High | $22.90 | $3.68 |
| Indicator | CVKD | WETH |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 49.26 |
| Support Level | $6.85 | $1.69 |
| Resistance Level | $7.87 | $1.97 |
| Average True Range (ATR) | 0.59 | 0.14 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 33.64 | 42.57 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.